When Dying Patients Want Unproven Drugs
After the ACT UP occupation, Grossman writes, the F.D.A. “never really resumed business as usual.” In 1992, it introduced a pathway called “accelerated approval,” which could be granted to drugs that showed an impact on a biomarker associated with a given disease (H.I.V. viral load, for example), even if they…
bubmagJune 19, 2023